Request Trial
Amanda Ebbutt, partner, and Paul England, senior counsel – knowledge at Taylor Wessing.
10 June 2025FeaturesEuropeAmanda Ebbutt & Paul England

Three reasons why the UK should reconsider joining the UPC

Two years since the UPC opened its doors, various developments might influence the UK government to reassess its position, write Amanda Ebbutt and Paul England of Taylor Wessing.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Europe
Top law firms and individuals recognised in WIPR’s UK Patent Rankings 2026
28 August 2026   This year’s tables provide a guide to the best of the UK market for legal advice on the protection, enforcement and exploitation of patents.
Europe
UPC hands Occlutech second win against Chinese medtech company in a month
19 June 2026   The court overturns a decision granting the German-based company provisional measures and ordering a Chinese medtech rival to stop selling its device in four European countries.
Europe
Exclusive: ‘Cultural differences are an asset’ at the UPC
16 June 2026   In the second of a series of interviews with women judges at the pan-European court, Ulrike Voß talks to Sarah Speight about her career, her views on the court so far, and how more women could be encouraged to join the judiciary.


Editor's picks

The buyers' wishlist: What makes a life sciences deal stack up?
Regulation & Industry
The buyers' wishlist: What makes a life sciences deal stack up?
25 August 2026

Editor's picks

Regulation & Industry
The buyers' wishlist: What makes a life sciences deal stack up?
25 August 2026
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
17 July 2026
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026

More features

Top law firms and individuals recognised in WIPR’s UK Patent Rankings 2026
UK appoints ex-engineer as new intellectual property Minister
Abbott fends off Chinese rival’s patent challenge at UPC
Former head of litigation at Nokia returns to Bird & Bird
Former USPTO acting director takes the helm at C4IP
Europe’s missing biotech bridge: Why IP ownership matters more than capital access
Novartis scores UK win in high-stakes Entresto fight
Invisalign maker secures first China win against clear aligner rival